Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 101 - 110 of 121 for biobay. (0.09 seconds)

BeiGene, the Beijing novel oncology drug developer, has...
Innovent Biologics of Suzhou raised $260 million in a...
The Medtronic-Sequoia China Healthcare Technology Venture...
BeiGene of Beijing is forming a $330 million JV, BeiGene...
Zai Lab of Shanghai partnered with GE Healthcare on...
Deals and Financings-- Beijing's BeiGene signed a record...
Shanghai's Zai Lab is planning a US IPO that could raise...
Suzhou's MabSpace Biosciences filed an IND application...
Innovent Biologics of Suzhou is planning a pre-IPO round...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here